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Abstract
Type 2 diabetes leads to premature death and reduced quality of life for 8% of Americans.
Nutrition management is critical to maintaining glycemic control, yet it is difficult to achieve
due to the high individual differences in glycemic response to nutrition. Anticipating glycemic
impact of different meals can be challenging not only for individuals with diabetes, but also
for expert diabetes educators. Personalized computational models that can accurately fore-
cast an impact of a given meal on an individual’s blood glucose levels can serve as the
engine for a new generation of decision support tools for individuals with diabetes. However,
to be useful in practice, these computational engines need to generate accurate forecasts
based on limited datasets consistent with typical self-monitoring practices of individuals with
type 2 diabetes. This paper uses three forecasting machines: (i) data assimilation, a tech-
nique borrowed from atmospheric physics and engineering that uses Bayesian modeling to
infuse data with human knowledge represented in a mechanistic model, to generate real-
time, personalized, adaptable glucose forecasts; (ii) model averaging of data assimilation
output; and (iii) dynamical Gaussian process model regression. The proposed data assimi-
lation machine, the primary focus of the paper, uses a modified dual unscented Kalman filter
to estimate states and parameters, personalizing the mechanistic models. Model selection
is used to make a personalized model selection for the individual and their measurement
characteristics. The data assimilation forecasts are empirically evaluated against actual
postprandial glucose measurements captured by individuals with type 2 diabetes, and
against predictions generated by experienced diabetes educators after reviewing a set of
historical nutritional records and glucose measurements for the same individual. The evalu-
ation suggests that the data assimilation forecasts compare well with specific glucose mea-
surements and match or exceed in accuracy expert forecasts. We conclude by examining
ways to present predictions as forecast-derived range quantities and evaluate the compara-
tive advantages of these ranges.
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Author summary
Type 2 diabetes is a devastating disease that requires constant patient self-management of
glucose, insulin, nutrition and exercise. Nevertheless, glucose and insulin dynamics are
complicated, nonstationary, nonlinear, and individual-dependent, making self-manage-
ment of diabetes a complex task. To help alleviate some of the difficulty for patients, we
develop a method for personalized, real-time, glucose forecasting based on nutrition. Spe-
cifically, we create and evaluate the computational machinery based on both Gaussian
process models and data assimilation that leverages the physiologic knowledge of two
mechanistic models to produce a personalized, nutrition-based glucose forecast for indi-
viduals with type 2 diabetes in real time that is robust to sparse data and nonstationary
patients. Our computational engine was conceived to be of potential use for diabetes self-
management.
Introduction
One promise of data science is the application of elegant solutions to new and important prob-
lems. In this way, personal health care can be seen as a prediction challenge: Identifying the
disease the patient has contracted—estimating the current state, forecasting the disease progres-
sion under different interventions—estimating the evolution of the state, and therapy—optimi-
zation of feedback to achieve target state. The ability to predict outcomes is important in
selection of treatment. It is also important for self-management of chronic diseases, as it can
help individuals to select the most beneficial self-management strategies and improve their
health. The increase in data related to individuals’ behaviors and health biomarkers opens an
unprecedented opportunity to use computational and data science methods to predict health
outcomes based on basic physiological knowledge and individuals’ historical records. How-
ever, to be useful in the real world, such methods need to generate accurate and actionable pre-
dictions based on realistic datasets that are consistent with current standards for health
monitoring.
Data assimilation (DA) [1], an application of filtering theory [2], pairs mechanistic models
with data via Bayesian statistics to create a forecast. It has been applied or deployed successfully
in fields including atmospheric physics and meteorology [3, 4], engineering [5], statistics and
computer science [6, 7], and, in a more limited way, biomedicine [8]. The power of DA is in its
ability to incorporate human knowledge into a forecast; in contrast to the more traditional
machine learning approaches, DA with mechanistic models does not require extensive datasets
and can be personalized and adapted quickly by estimating mechanistic model parameters. As
a result, such models can arrive at an accurate forecast with data that are fewer, more sporadic,
or incomplete. The use of DA and control theory in medicine is relatively rare and has been
applied in limited situations where data are collected in highly controlled data-rich environ-
ments. Examples include algorithms in implantable defibrillators and pacemakers to cope with
irregular heartbeats [9–13], model construction and fitting for prostate cancer treatment [14],
epidemiology [15], and the artificial beta-cell or pancreas project designed to manage insulin
and glucose for individuals with type 1 diabetes [8, 16–20].
Here we focus on DA for uses related to type 2 diabetes. Diabetes mellitus is a high-impact
disease. In 2012, 8.3% of all Americans and 25% of Americans over the age of 65 had diabetes.
It is the 7th leading cause of death in the United States, and costs associated with this disease
amount to $176 billion in direct medical costs and $69 billion in reduced productivity in 2012.
Type 1 diabetes is an autoimmune disease that destroys pancreatic beta cells and typically
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renders the body unable to produce insulin. Type 1 accounts for 5% of patients with diabetes.
The remaining 95% of diabetic patients have type 2 diabetes [21], a disease with complex
causes (cf. Fig. 1 of [22]) where the individual remains capable of producing insulin but has
elevated glucose levels.
The main approach to diabetes management is maintaining blood glucose within ranges
considered safe. For diabetes patients, such maintenance is done through a combination of
nutrition management, physical activity, and medication. Hemoglobin A1c (HbA1c), a physi-
ologic measurement that correlates to a three-month average of blood glucose [23], is a clinical
indication commonly used to evaluate diabetes management. Elevated HbA1c values above
8% lead to elevated mortality [24], while individuals with HbA1c in the near normal range of
6–6.5% have improved outcomes [25, 26]. These observations have led to the clinical goal of
reducing HbA1c to near normal levels of 6–7% [25, 26] when possible, and maintaining below
8% in nearly all circumstances. From the perspective of self-management, HbA1c normality
serves as a long-term goal for patients, but has little practical utility in guiding individuals’
daily choices. Instead, individuals with diabetes self-monitor daily blood glucose readings;
higher frequency of self-monitoring of glucose has been associated with better glycemic con-
trol and improved clinical outcomes [27–29]. The current recommended frequency of glucose
self-monitoring for individuals on intensive insulin regimens is 6–10 times daily; however, no
clear guidelines are available for individuals who use basal insulin or oral agents [30].
Nutrition-based glucose management is hard to achieve because it is difficult to understand
the impact of foods on glucose levels on a meal-by-meal basis [22, 25, 26, 31]. Glucose-insulin
dynamics are high-dimensional, nonlinear, oscillatory, noisy, multi-scale, and dependent on
many personal and demographic factors [22]. Studies have demonstrated great variability in
individuals’ glycemic response to meals with identical nutritional composition [31]. Anticipat-
ing the impact of different meals on one’s blood glucose levels is challenging for both individu-
als with diabetes and diabetes educators [32]. This personal diversity and forecasting difficulty
has led the American Diabetes Association to recommend personalized treatment [33]. There
is a clear need for tools and mechanisms that assist individuals with diabetes in understanding
and predicting the impact of their nutritional choices on glucose levels and identifying
approaches to regulating nutrition to minimize its glycemic impact.
The method requirements to implement personalized forecasting for type 2 diabetes (diabe-
tes will refer to type 2 diabetes unless otherwise noted) glucose management differ from data-
rich applications because diabetes data are collected primarily by patients and are sparse, irreg-
ularly measured, and noisy. A recent study examining fluctuations in glucose levels for non-
diabetics in response to nutrition, physical activity, and sleep established feasibility of utilizing
machine learning methods when high density data on glucose levels is available through con-
tinuous glucose monitoring [31]. However, because continuous glucose monitoring continues
to be out of reach for the vast majority of individuals with diabetes, these data-dense methods
are not likely to lead to practical solutions in the near future. Because of this gap, we focus on
forecasting glucose in scenarios consistent with common self-monitoring practices of individ-
uals with diabetes. We extend DA to clinical settings that lack tight monitoring and are subject
to the constraints of collecting data in real-world clinical situations where the data are com-
plex, irregularly sampled, and biased [34].
Glucose prediction in the context of diabetes has been studied by researchers across many
disciplines, and has resulted in a diversity of data-driven approaches for personalized glucose
forecasting [35, 36]. These efforts have attempted different tasks (e.g. prediction of hypoglyce-
mia [37–39], glucose control [36, 40–45], and physiologic inference [41, 46–49]), and have
taken a variety of approaches to identifying suitable models of a diabetic’s glucose system (e.g.
nonlinear Weiner model [40, 41, 50], neural networks [42], probabilistic models [38], and
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mechanistic systems of ordinary differential equations (ODEs) [48, 49]). Many of the desired
prediction tasks have been approached by wrapping the aforementioned models in different
predictive algorithms and inference schemes (e.g. stochastic filters [44], PI controllers [45, 51],
Gaussian process models [52], fuzzy logic [45], and many other machine learning methods
[36, 37, 39, 53]). These studies have paved the way towards personalized interventions for peo-
ple with diabetes, but most studies fail to show their applicability in settings where data are
restricted to those with realistic qualities.
A number of recent studies have begun to focus more on this point of realistic applicability.
Zitar and Al-Jabali demonstrated that neural networks could be constructed, based on mecha-
nistic ODEs, to fit a large real-world data set of type 2 diabetics, but lacks sensitivity to nutri-
tion, making the approach less useful for personalized nutritional adjustments [42]. Beverlin
et al., on the other hand, demonstrated that glucose predictions can be generated with low
error and high correlation by fitting a nonlinear Weiner box model to four patients with type 2
diabetes [40, 41]. However, their model was trained with glucose data sampled every 5 minutes
by an implantable sensor, which is neither used nor recommended for the majority of people
with type 2 diabetes. Barazandegan et al. proposed the use of online sequential Monte Carlo
estimation using a mechanistic model of glucose-insulin dynamics in response to nutrition
developed by Vahadi et al., and demonstrated that sequential importance resampling particle
filter can be used for accurate individualized forecasting, even in the presence of missing and
noisy data [44, 46, 48]. However, this work was based entirely on simulated data, rather than
free-living biological data. The research presented here aims to bridge the gap in the literature
between proposed methods for personalized glucose forecasting and evaluation of those meth-
ods on real-world data. We fit a mechanistic model of type 2 diabetes glucose dynamics ([49])
using a simple data assimilation strategy for sequential estimation (unscented Kalman filter
[54]), and demonstrate the efficacy of this approach in 3 individuals with type 2 diabetes and 2
individuals without diabetes who only used a smart phone application to capture pre and post-
meal glucose readings and descriptions of their meals.
The goal of the research presented here is to generate personalized, accurate, and actionable
predictions of glucose in response to nutrition that can assist individuals with diabetes in mak-
ing quantitatively informed nutritional choices. Our solution uses DA to translate the systems
physiology knowledge of glucose-insulin dynamics encoded in mechanistic models into a clin-
ical context to create personalized modeling engines capable of generating nutrition-based,
post-meal glucose and HbA1c forecasts in real time. These forecasts would then be integrated
into mobile applications such as the one developed by Mamykina et al. [32]. To make the
information useful for individuals with diabetes, these forecasts must: (i) use the minimally
invasive data that diabetes patients collect in routine care, up to a maximum of 6–10 measure-
ments a day, (ii) personalize to the individual and adapt to changes in behavior and health-
state, (iii) work in real time, and (iv) be accurate enough to produce a forecast that can differ-
entiate glucose values that correspond to between 0.5–2% differences in HbA1c values.
Our solution is constructed and evaluated in eight steps. The data assimilation-based solu-
tion is developed and internally evaluated in the inital five steps. Then we show how the DA
methodology can potentially be generalized using model averaging in step six, compare the
DA against non-personalized versions of itself and with machine learning-based forecasting in
step seven, and then demonstrate how the DA output could be translated into a more useful
form in step eight. In more detail: First, we develop the DA framework within the context of
diabetes. Second, we show that the DA can generate a personalized forecast using data collected
routinely by individuals with diabetes. Third, the DA predictions are shown to have similar
and sometimes higher correlation with measured postprandial glucose levels than predictions
generated by Certified Diabetes Educators who rely on their extensive knowledge and
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experience, and whose predictions, from the perspective of the patient trying to estimate the
glycemic impact of their meal choices, represents the current clinical gold standard prediction.
Fourth, we show that the DA will not only adapt to the individual, but will also adjust with
minimal data when the individual changes behavior quickly. Fifth, because there is no single
model that will provide the best forecast in all situations, we use statistical model selection
[55–57] to pick the best model for each individual given their data capture habits and the
employed DA strategies. Sixth, armed with the individual model performance results and
motivated by achieving the most robust and accurate possible forecast, we show how model
averaging techniques can be used to improve model forecast performance. Seventh, to demon-
strate the impact of tracking states and parameters on a forecast and to contrast the mecha-
nism-based DAs with more traditional machine learning techniques, we generate forecasts
using DAs with the state and parameter filters turned off in parallel with a dynamic Gaussian
process model. And eighth, we take initial steps towards establishing glucose level forecast
accuracy benchmarks for individuals with diabetes by examining accuracy of individual fore-
casts generated using DA over a period of time relevant for self-management.
Roadmap for the rest of the paper. This paper is not the least complex and parts of it can
be read independently of other parts. To help make reading the paper easier, we are including
a descriptive outline of the paper. The methods section has five components: (i) DA, the mecha-
nistic models, and basic model selection and evaluation tools, (ii) DA-based model-forecast
averaging, (iii) dynamical Gaussian process models, (iv) the study designs and data we use in
the paper, and (iv) validation methods for the DA and its forecasts. The results section has
seven components: (i) DA-based glucose state estimation and convergence, (ii) a comparison
between DA-based postprandial glucose forecasts and certified diabetes educator-based post-
prandial glucose forecasts, (iii) personalization of models though DA-based parameter estima-
tion, (iv) model selection and evaluation, (v) model averaging, (vi) a comparison between the
Gaussian process model forecasts and the DA where sub-filters, e.g., state and parameter fil-
ters, are turned off, and (vii) a consideration of the potential impact of a clinical intervention.
The discussion section has two large components: (i) a summary of our results and related dis-
cussions, and (ii) a more broad discussion of issues related to applying DA in clinical and bio-
logical contexts. Many of the results and discussion sections can be read relatively
independently assuming the reader understands the relevant methods introduced in the meth-
ods section.
Materials and methods
Development of the data assimilation framework with two endocrine
models relevant for diabetes
Data assimilation (DA) is a data science machine that unifies models with data to reconstruct
the model state and provide forecasts. Crudely, DA is a sophisticated interpolation and fore-
casting scheme. We focus on the use of mechanistic models that represent human understand-
ing of the system dynamics, although versions also exist for unsupervised models as well. Our
objectives here are to reconstruct the state of the endocrine system relevant to glucose-insulin
dynamics regulation from the sporadic blood-glucose measurements clinically expected from
a patient with diabetes. A detailed explanation of the methods we use can be found in S1
Appendix.
Concretely, the objective of a DA filter is to reconstruct and predict state xk of a system
from noisy, sparse measurements yk, where k indexes time. Inherent in this process is assumed
uncertainty in how well the state xk is known. Therefore a distribution of state is assumed and
tracked. Because of the combination of the nonlinear, high-dimensional dynamics of the
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endocrine models and the sparsity of the data, we utilize a variant of an unscented Kalman fil-
ter (UKF) or Bayesian sigma point processor [7, 58–61] for DA. Critical in our implementation
are the capacities to accommodate sparsely and non-periodically acquired data appropriate for
diabetic monitoring and non-stationary system parameters consistent with changes in patient
behavior and physiology.
State estimation. Kalman filter-based methods utilize a prediction-correction scheme to
dynamically track and adjust both the system state and its uncertainty to agree with measure-
ments as they are made: the system model _xðtÞ ¼ f ðx;wÞ as a function of state x and parameter
w is used to iterate the distribution of system state forward in time to produce a prediction; the
prediction is then corrected to both adjust the prediction and collapse its uncertainty. The
objective is to determine the best estimate of state, denoted x^ðtÞ.
The Unscented Kalman Filter serves the function of smoothing the data in the sense of
reconstructing a best, de-noised estimate of all state variables from noisy, incomplete measure-
ments made at times {tk}, and to provide extrapolated estimates of state for all times. For times
ahead of the most recent measurement at time tk−1, with best estimate x^k  1, these extrapola-
tions x^ðtjx^k  1Þ (later referred to as χo, due to its relationship to the central sigma point as
described in the Appendix) provide forecasts of future state:




¼ Fðx^k  1;w; t   tk  1Þ ð2Þ
The forecast at the next measurement time x^kjk  1 ¼ Fðx^k  1;w; tk   tk  1Þ is then corrected to
agree with measurements yk in proportion to the difference between this forecast and measure-
ment,
x^k ¼ x^kjk  1 þ Kkðyk   y^kjk  1Þ ð3Þ
where y^kjk  1 is the projection of x^kjk  1 onto the measurement subspace spanned by y. The Kal-
man gain Kk is derived from a linearization of the dynamics’ flow about x^kjk  1, and provides
correction of all state variables from the subset of ones actually measured. Once corrected, the
new best estimate x^k is used to generate revised future predictions until another measurement
is made, while x^ðtjx^k  1Þ serves as a smooth extrapolation of x^ for tk−1 < t< tk. A full descrip-
tion of the UKF can be found in S1 Appendix.
The unscented Kalman filter efficiently accommodates nonlinear models by assuming the
state is a multivariate Gaussian distribution around the best estimate x^k, whose covariance rep-
resents the state uncertainty, and then propagating x^k and a representative finite set of symplex
points used to approximate the distribution—denoted as sigma points—forward through the
dynamics. The spread of the forward iterates of these sigma points then represent the forecast
uncertainty, and their covariance is used to compute the Kalman gain at the next correction
step. The appendix contains a detailed explanation of the unscented Kalman filter we use here.
The application of DA to biological and clinically relevant models is not in itself novel. The
application of DA to type 2 diabetes using data constrained to normal everyday patient collec-
tion is novel because this application poses particular challenges: the clinical environment is
data-poor because data collection is strictly constrained to real-world patient self-measure-
ment patterns, the lack of a first principles model allows for multiple possible best models, and
the reality of non-stationary health implies non-stationary model parameters. We address each
of these issues below.
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Model choice, evaluation and selection. There are numerous models of glucose-insulin
dynamics of varying complexity [62], and it is neither obvious a priori which of these will best
fit and predict the relevant dynamics from the limited measurements made, nor whether such
optimization may be patient specific. For this study we have limited our analysis to the com-
parison of two models chosen for their balance between modeled mechanisms and limited
complexity: First, we use a relatively simple ultradian model [63] with 6 state variables and 30
parameters. This model is a minimal model developed in a non-pathophysiologic context and
represents relatively simple physiologic mechanics. Second, to contrast the ultradian model we
use the meal model [49] with 12 state variables and 70 parameters. The meal model includes
more digestive mechanics, was developed to include both physiologic and pathophysiologic
dynamics, and represents a substantial increase in mechanical modeling complexity over the
ultradian model. Each of these models are utilized in the DA framework to reconstruct and
forecast the glucose dynamics from patient recorded data. The fidelity of the forecasts is then
used to differentiate model performance. The full details and descriptions of the models are
included in S2 and S3 Appendices.
Parameter selection and estimation. Because of differences between individuals and the
non-stationary nature of their behavior and health, we personalize the application of these
models by estimating and continually refining model parameters in real-time. Parameters are
estimated using a parameter filter that is analogous to the state filter where the states are
replaced with parameters.
Due to the practical overfitting constraints imposed by sparse data collection, only a small
subset of the parameters—three parameters per model—are continually refined. We chose the
parameters to estimate using physiologic insight and motivation towards the clinical goal of
post-meal glucose forecasting by restricting the estimated parameters to those that strongly
influence the mean and variance of glucose. Moreover, we chose parameters that are relatively
independent of one another to maximize the effective parameter space and reduce parameter
interdependency issues within the parameter filter. Although the measurements are quite
sparse, they include measurements just before meals, providing a baseline, and measurements
taken at various times after meals, helping to capture variation in glucose dynamics. The result
is not only a patient-specific model and forecast, but one that adapts over time with changing
individual behavior. It may be possible to devise an optimal measurement pattern but we do
not address this topic here. Because the models we use embody established physiological sys-
tems and their dynamics, the parameters themselves have direct physiological interpretation.
We therefore hypothesize that parameter changes detected over time may be useful indicators
of changing health, a topic we address in more detail in the discussion.
Data assimilation for states and parameters—Methodological summary. We developed
a modified dual unscented Kalman filter (UKF) that uses two separate filters to estimate states
and parameters. The state filter was modeled after Wan and van der Merwe [61], but augmen-
tation of posterior sigma points was done in proportion to the estimated posterior covariance,
rather than with respect to an assumed noise term (Appendix, eq. 28-29). The parameter filter
was implemented as defined by Gove and Hollinger [58], where prior parameter covariance is
inflated by a “forgetting factor” to allow an additional growth of parameter uncertainty pro-
portional to its covariance, rather than with respect to an assumed noise term (Appendix, eq
46-47). In addition, we enforce a positivity constraint on parameter and state sigma points by
setting negative elements to the smallest positive value taken by that element across all sigma
points. If no positive values are present, we set the element to zero. Negative (non-physical)
parameters and states are inappropriate for the models we use, and can lead to problems with
numerical integration, which can subsequently erode the quality of the fit. These ad-hoc
adjustments can lead to ill-conditioning of the updated covariance—to overcome this, we
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generate the next iteration of sigma points with only the real part of the covariance square
root. These constraints introduce their own weaknesses, and can lead to underfitting through
pre-mature parameter convergence in cases where much of the volume of the covariance
square root exists in the complex plane. While this approach is certainly suboptimal, we find it
useful for ensuring robustness in an algorithm that must perform reliably in an online clinical
setting.
Clinical variable estimation. The UKF generates continuous smoothed estimates of states
and parameters that can be used to compute estimates of clinically relevant measures, e.g.,
HbA1c. Clinically, HbA1c is linearly related to the mean of the glucose over the previous three
months [23] and summarizes glucose control over that time period. Because HbA1c is an aver-
aged value of blood glucose over a 3-months timeframe, individuals can find it difficult to
relate this average to any particular meals or other activities that contributed to it. This prob-
lem exists largely due to the sparsity of glucose data collection—individuals don’t collect
enough measurements to calculate an accurate average over short time periods. The continu-
ous state UKF estimates allow for short term—order hours to months—moving window mean
glucose estimates, providing an opportunity for individuals to understand the source of their
HbA1c by understanding quantitatively the events that compose their mean glucose over short
time periods related to nutrition consumption.
Data utilized. The data we use in this paper reflect our goals of proving that a DA can:
(i) successfully forecast glucose based only on data typically available to individuals with diabe-
tes: carbohydrates in meals and sparse, irregularly sampled glucose measurements, (ii) person-
alize to an individual, (iii) adapt when the individual changes, and (iv) cope with the data-poor
constraints of real-life diabetes self-monitoring. Because of these goals, we restricted the data
to three individuals with diabetes chosen to capture specific disease and measurement charac-
teristics. Participant 1 measured glucose with a frequency at the upper bound of what is com-
mon among individuals with diabetes (1 preprandial and 1–3 postprandial) and self-reported
a change in their diet over the course of the study. Participant 1 has well controlled diabetes,
with pre- and post-study HbA1c measurements of 6.4% and 5.6%. Participant 2 measured
blood glucose in accordance with a typical clinical recommendation for individuals with dia-
betes (preprandial and 2h postprandial) and did not report any changes in their diet over the
course of the study; this participant’s HbA1c at the end of the study was 6.4%. Participant 3
contributed the most sparse and irregular dataset, which included irregular records of meals,
days with no records, and glucose captured at random times of day often without reference to
meals. This case is included to demonstrate the relative success of the DA forecasts in data-
poor situations that imply its particular relevance in real-world practice. Moreover, while par-
ticipants 1 and 2 represent best-case self-monitoring among people with type 2 diabetes, par-
ticipant 3’s data presents a snap-shoot of are more average to low level of self-monitoring
common among people with type 2 diabetes. Participants 4 and 5 do not have diabetes but
were participants in a usability study for a later generation of the mobile application used dur-
ing the collection of data from participants 1 and 2. We have included participants 4 and 5
because they are physiologically distinct from the participants 1–3 and this difference both
increases our data set and provides more evidence of the robustness of the methods we develop
in this paper.The details of the data and its collection are included in the methods section.
Model averaging
The model averaged output quantity, g^ , is estimated from a set of models fi, a set of continuous
and potentially nonlinear functions that translate the model output into a g^ -compatible form.
Here g is the mean of the posterior distribution or the mean of the sigma points output by the
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where we assume M models and positive weights wi that sum to one, or
PM
i¼1 wi ¼ 1. Due to
this constraint, M − 1 weights wi are sufficient to determine g^ ; thus, with two models, we seek
the optimal value of w1. There are many methods for selecting the optimal weights where opti-
mal is defined by the set of weights such that g^ minimizes a model evaluation metric, three of
which are introduced in the sections that follow.
Linear prediction based model averaging. A clinically relevant and intuitive method for
selecting the model averaging weights is to maximize the linear correlation between forecasts
and measurements over some time period. Or, assuming measurements y and forecasts xi gen-
erated by model i on a time period T we estimate the linear correlation with:
yðTÞ ¼ bðw1x1ðTÞ þ w2x2ðTÞÞ þ  ð5Þ
and we select the weight w1 that maximizes the linear correlation, β.
Mean square error based model averaging. Possibly the most common method for
selecting the model averaging weights is to minimize the mean squared error (MSE) between
forecasts and measurements over some time period. Or, assuming N measurements y and fore-






ðyðtiÞ   ðw1x1ðtiÞ þ w2x2ðtiÞÞÞ
2
ð6Þ
and we select the weight w1 that minimizes the MSE.
Information criterion based model averaging. The information criterion ([56]) model
evaluation method we use here is based on the Kullback-Leibler divergence ([64]). This
method focuses neither on prediction, like linear correlation evaluation, nor error, like MSE
evaluation, but rather on the overall closeness between the distributions defined by data and
model forecast output. The intuitive interpretation of KL-divergence between two distribu-
tions p and q is the information lost when approximating p with q. In the context of model
averaging, we formulate the KL-divergence as:
KLðw1;w2Þ ¼
Z




where p(w1 x1(T) + w2 x2(T)) is the kernel density estimate (KDE) of the model averaged fore-
casts and q(y(T)) is the KDE of the data. We select the weight w1 that minimizes information
loss, or KL(w1, w2).
Gaussian process regression model
Some previous studies have used non-mechanism-based machine learning methodology to
forecast post meal glucose. We do not use continuous glucose monitor data here and therefore
cannot directly compare the DA output with what has been done in other studies, but we can
use machine learning methods on our data and compare those forecasts with the DA forecasts
to some degree. In the same spirit as was used with the UKF—we use standard methods and
do not optimize hyperparameters to simulate what is possible in the high-throughput setting—
we use a Gaussian Process Model Regression (GPMR) [65] modified for next step prediction
[66]. The theory for these regressions is well-known, so we will not discuss it in detail here.
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However, it is necessary for us to explain the details of the methodology we use for training,
forecasting, and evaluating the GPMR. The regression takes two input variables, pre-meal glu-
cose defined as a glucose measurement within 15 minutes of eating and the carbohydrate con-
tent of a meal. The output is the post meal glucose forecast that is independent of time and
represents a post-meal glucose value. The GPMR will be trained initially on 50 meals; when
new meals are encountered, a post-meal glucose forecast will be made, and then that meal will
be incorporated into the training set for the next, yet to be observed, meal. In this way, the
training set increases with every meal while the post-meal glucose forecast is always made for a
single meal as it would be encountered in real time. The post-meal glucose forecast is com-
pared with the first post-meal glucose measurement on a time interval of 45–180 minutes after
the meal. Because of these data constraints, the GPMR cannot be used to forecast pre-meal glu-
cose, glucose at random times, or glucose without a meal and without a pre- and post-meal
glucose measurement, and therefore there are fewer meals available to forecast. Because of
these practical issues, the GPMR uses a different training set than the UKF schemes. As we
have mentioned earlier, there is a lot of space for improving both GPMR and UKF or more
broadly DA inference machines, a topic we will address in the discussion.
There are two details worth mentioning related to DAs with mechanism-based models and
GPMR. First, both the DAs and the GPMR we use in the paper are Gaussian processes in the
formal sense [67], but their primary dynamics are generated by very different processes, one
mechanistic with a random component and one has only a random component. Second, the
DAs generate continuous forecasts and therefore can forecast all glucose measurements
regardless of the data available, making them flexible and robust to missing or partially missing
data.
Study design
In this study, we create the mechanistic model-based glucose forecasting machinery with data
assimilation that provides real-time, personalized glucose forecasts that adapt to and track an
individual patient’s changing state over time, and we validate it on longitudinal time series
from five patients. We demonstrate that the DA forecasts, subject to real world constraints of
sparse, noisy, real patient-collected data, personalize, adapt over time, and track quickly rela-
tive to postprandial blood glucose readings captured by the participants, such that the DA
machinery can be used as the engine in a diabetes self-intervention application. Through the
DA we translate physiologic knowledge directly to an individual to help them make disease
self-management decisions. The DA we use is designed to track, forecast, and correct states
and parameters of nonstationary systems in real time without the luxury of an explicit training
set. Instead, the algorithm is adjusted to each patient, using the prior data for training and pre-
dicting unseen subsequent data points. Similar methodology was used in the DA model aver-
aging construction. The GPMR construction differs as is demanded by the details of the
GPMR computation. It is initialized with a training set of 50 meals when possible and then
forecasts post-meal glucose given carbohydrate and pre-meal glucose measurements. For the
DA, we use two independent mechanistic-model-based DAs to forecast because different indi-
viduals, or individuals in changing states, may require different mechanistic models as fore-
casting engines. We also develop the model selection criteria for evaluating and selecting the
most accurate model, given a prediction task, in the results section.
The five independent datasets chosen represent typical self-monitoring scenarios for indi-
viduals with type 2 diabetes from three different diabetes studies. The first three participants
have type 2 diabetes while the last two participants do not. In addition, we compared accuracy
of the DA predictions with accuracy of predictions generated by certified diabetes educators,
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whose judgement often represents the gold standard with respect to human-based post-meal
glucose prediction and is used to arrive at nutritional therapy recommendations for individu-
als with diabetes. We compare the DA forecast to that of the diabetes educators to demonstrate
that the DA can perform as well as the most skilled humans. This evaluation is important
because it compares human and machine accuracy for the prediction task that people with
type 2 diabetes must perform every time they consume food. We chose an N of five because
our goal is to understand and validate the personalized performance of the DA in depth. In
this way we performed five independent experiments and compare their outcomes. We have
two layers of inclusion/exclusion requirements, those for this paper and those of the original
studies where the data originate; the details of the data collection for the diabetes studies are
discussed in paragraphs below and the related citations. For this study we chose five individu-
als with the following characteristics:
1. (i) more than two measurements over the course of a meal, (ii) relatively dense measure-
ments in time, (iii) changing patient state over course of measurement., (iv) type 2 diabetes.
2. (i) two measurements over the course of a meal (before and after), (ii) realistic, sustainable
measurements in time, (iii) static patient state over course of measurement, (iv) type 2
diabetes.
3. (i) relatively random measurement times, (ii) sparse measurements in time, (iii) unknown
patient state over course of measurement, (iv) type 2 diabetes.
4. (i) more than two measurements over the course of a meal, (ii) relatively dense measure-
ments in time, (iii) changing patient state over course of measurement., (iv) non-diabetic.
5. (i) more than two measurements over the course of a meal, (ii) relatively dense measure-
ments in time, (iii) changing patient state over course of measurement., (iv) non-diabetic.
Their data are shown in more detail in Table 1. We did not exclude data outliers because we
want to show the DA performance under realistic, real-time circumstances. Each participant is
treated as an independent experimental set-up, and the number of glucose measurements rep-
resent the number of experiments per experimental set-up.
Diabetes data collection studies. The three datasets included in the analysis were col-
lected during two separate studies with individuals with diabetes. Participant 3 was a partici-
pant in a randomized controlled trial of a mobile application for diabetes self-management,
MAHI [68]. Participants 1 and 2 took part in a study that investigated how individuals with
diabetes reason about personal data collected with self-monitoring technologies [32]. All three
datasets included images of meals taken with smart phones, unstructured textual descriptions
of these meals, and blood glucose readings captured at different times of day. During the first
Table 1. Demographics, data characteristics, and medication information for the five individuals we used to evaluate the DA. Each participant is
treated as an independent experimental set-up, and the number of glucose measurements represent the number of experiments per experimental set-up.
Demographic and medication information for five individuals used in our study
ID 1 2 3 4 5
Disease state DM2 DM2 DM2 no-DM2 no-DM2
Age 40–50 40–50 40–50 40–50 40–50
Meds metformin metformin insulin none none
# of glucose measurements 304 211 24 520 322
# of HbA1c measurements 2 1 0 0 0
# of days measured 27 28 15 90 90
https://doi.org/10.1371/journal.pcbi.1005232.t001
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study (participant 3), the participants were asked to follow their typical glucose testing sched-
ule; as a result, the first dataset included sparse glucose readings taken 2–3 times per day and
often irrespective of meals (e.g. only before or only after). In the second study (participants 1
and 2), the participants were explicitly asked to check their glucose readings before meals, and
at least once (2 hours postprandial) or more after meals. Consequently, data sets for partici-
pants 1 and 2 include considerably more glucose readings, 7–11 daily. Importantly, while the
first study was an intervention study, designed to instigate changes in participants’ behavior
over its course, the second was a data collection study without an interventional component or
expectations for changes in participants’ behaviors. Yet qualitative interviews with participants
of the second study, particularly participant 1 suggested that simple participation in the study
alerted them to their nutritional choices and led to some changes in their diet (which was con-
sistent with the change in their reported HbA1c). In contrast, participant 2 did not report any
changes in their diet. The demographic information of study participants and statistics on the
captured data are included in Table 1. Both studies were approved by the corresponding Insti-
tutional Review Boards; all participants signed informed consent form prior to participating.
In both studies the participants were reimbursed the cost of testing strips.
Diabetes educator prediction data collection study. To compare the predictions of the
model with best available human-based glucose predictions, we used predictions of postpran-
dial glucose levels collected during our previous study of reasoning with personally generated
data [68]. In that study, two Certified Diabetes Educators were asked to review meals, their tex-
tual descriptions, macronutrient breakdown of those meals, and glucose readings before and
after those meals extracted from data sets collected by participants one and two. The extracted
sets included records made during 5 consecutive days. After that, the diabetes educators were
presented with records of meals captured during another 5 days (not included in the previous
phase) and glucose levels before these meals, and were asked to predict postprandial glucose
levels (at 1h and 2h postprandial for participant one and at 2h postprandial for participant
two). We previously reported on these results in comparison with predictions generated by
individuals with diabetes. Here we use the diabetes educator forecasts, the best available
human-generated predictions, as a point of comparison with the DA glucose forecasts. If the
DA forecasts are comparable to those of the best human forecasts, the case can be made that
the DA forecasts could be potentially made useful to individuals with type 2 diabetes.
Non-diabetes data collection study. Data for non-diabetic individuals was collected as
part of the pilot study of a smart phone application for forecasting individual’s glycemic reac-
tion to prospective meals based on their previous history. The two individuals whose data was
used in this paper were recruited as part of a convenience sample, were both in their early 40s,
had no known health issues, varied in gender (one male, one female), and had college degrees.
They used the app for 4-6 weeks each to capture all their meals and blood glucose levels before
and after each meal (2 hours postprandial) for the duration of the study.
All of the studies were approved by the corresponding Institutional Review Boards; all par-
ticipants signed informed consent form prior to participating. In all studies that involved col-
lecting blood glucose readings, the participants were reimbursed the cost of testing strips.
Evaluation, validation, generalizability and usability of the model-based
UKF construction
In this paper we address the validation or evaluation, generalizability, and usability of the
mechanistic model-based UKF forecasts. The UKF is a prediction/correction machine, mean-
ing that it uses the most recent data to make predictions until the new data point is encoun-
tered, at which point the prediction is evaluated and the UKF states and parameters are
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corrected. This implies a different validation and generalizability situation from what is often
encountered in biomedical studies.
Validation of the UKF, because of the prediction/correction construction, requires each
person to be treated as an independent experimental set-up. Therefore, sample size for valida-
tion is the number of meals per person. For validation purposes, we conducted five experi-
ments on different experimental set-ups where the experiments range from having sample
sizes of 24 to 520. We validate the model/UKF combination using mean squared error, linear
correlation, and a KL-divergence-based distance on a per-person/experiment basis. Moreover,
we compare expert nutritionist forecasts to model forecasts, but this is not so much a valida-
tion of the UKF as it is a quantitative validation of the challenges that individuals with type 2
diabetes face in the course of their self management and a demonstration of a way the UKF-
based forecast could potentially help individuals with type 2 diabers. The nutritionist is the
gold standard baseline for human-based prediction of the glycemic impact of a chosen meal.
Therefore, when we compare the nutritionist forecasts with the model-based forecasts we are
comparing machine-forecasting to human-based forecasting to demonstrate the potential use-
fulness of the UKF framework. It is important to understand that the nutritionist is not the
gold standard by which we evaluate the UKF, the glucose measurements serve that purpose.
Generalizability moves beyond validation of the UKF and addresses the likelihood, for a
population, that the UKF equipped with one or another of the mechanistic models would be
applicable. Relative to generalizability to the population of human beings, we have a sample
size of five including three individuals with type 2 diabetes and two individuals without type 2
diabetes. While these five individuals are rather diverse and have different disease states with
only five people we cannot claim that the models or the UKF will generalize to all people. How-
ever, this is not the purpose of this paper; before justifying imposing the UKF on a larger popu-
lation, it is important to validate and understand, on an individual level, the accuracy of the
UKF forecast and how well the UKF can personalize to different individuals.
Usability moves beyond validation but in a different direction than generalizability. Usabil-
ity addresses the usefulness, to a person with type 2 diabetes, of the UKF output. To address
usability one must address the consistency of the accuracy of the UKF output and the nature of
the presentation of the UKF output. For example, the usability is often quantified based on the
impact of the presentation of the forecast on the patient state as the study progresses. The ret-
rospective nature of this paper and the limited population size prevent us from addressing
usability in earnest here. What we do instead is investigate the building blocks for a potential
diabetes management intervention. We do this to help put the UKF forecasts in a more clinical
context and justify that the UKF forecasts can be of potential use for a diabetes intervention.
But a first set in any usability study is to understand the accuracy of the information given to
the users—this paper was written with this step in mind.
Results
Glucose state estimation using data assimilation
The visualization of the personalized glucose forecasts from both models, the continuous glu-
cose imputation, and the convergence to better forecasts as more data are accumulated for par-
ticipant 1 is shown in Fig 1. To demonstrate the model forecasts at the beginning and how
they improve over time, we have included plots of forecasts for days 1–5 and 20–25. In these
plots, the DA receives data as if it were collected in real time, makes forecasts, corrects the glu-
cose trajectory and model parameters according to each individual measurement, and then
repeats this process. There are four features in Fig 1 of note. First, the models seem to converge
over time and provide better forecasts. Second, the models appear to generate accurate
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forecasts. Third, the glucose dynamics of both model-based DA outputs lie within the range of
measured glucose values. And fourth, the off-data model dynamics differ substantially between
models despite the similar accuracy of both model forecasts.
While the DA output looks reasonable in Fig 1, it is important to quantify the goodness of
fit. Fig 2 shows the mean squared error between the real-time DA forecasts and the measure-
ments over time for both models. There are three notable features in Fig 2 First, the models
converge after about 50 measurements—at 8 glucose measurements per day, convergence is
achieved with about one week’s worth of data. Second, while the ultradian model does better
initially relative to the mean squared error, the models provide approximately equally accurate
forecasts given two to three weeks of data. And third, the mean squared error improves over
time—most of the point-wise mass of the mean squared error lies below the mean, implying
that much of the post-convergence error is generated by a few large-error forecasts.
Comparing DA glucose forecasting to Certified Diabetes Educator
forecasts
We have established that the DAs converge and generate accurate forecasts; the next question
is to compare predictions generated by the model with those generated by human experts,
here Certified Diabetes Educators. To be clear, we are not using the diabetes educators as a
gold standard for the DA but rather as a gold standard for human-based forecasting of the gly-
cemic impact of individual meals. There are two reasons why we want to compare diabetes
educators to the UKF forecasts. First, while human-based glycemic forecast evaluation is not
the topic of this paper, it is important that we demonstrate the difficulty of the task we are ask-
ing of patients, every time they eat, by showing how well a highly educated/trained individual
performs at the task of forecasting glycemic impact of a given food intake. Second, we need to
have a proof in principle from a clinical standpoint that the DA predictions of by-meal glyce-
mic impact were comparable or better than to what a trained diabetes counselor would fore-
cast for individual meals; i.e., demonstrating that the DA can do as well as the best trained
Fig 1. Glucose measurements, forecasts, corrections, and continuous forecasts of both models for days 1–5 (left) and 20–25 (right) for
participant 1. These representations of the tracking and forecasting processes performed by the UKF provide an intuitive understanding of the
estimation procedure, as well as for the dynamics of each model. Forecast errors are generally larger for both models during early stages of
training (days 1–5), but while both models produce similarly reasonable forecasts of each discrete measurement (which we establish
quantitatively), both models predict qualitatively different off-data continuous forecasts, represented by the lines, over the same time periods and
subject to the same measurements; this difference demonstrates that the models represent different physiology.
https://doi.org/10.1371/journal.pcbi.1005232.g001
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humans at forecasting glycemic impact. By doing this we can establish a proof in principle,
from the clinical standpoint, that with little tuning the DA could automatically match or beat
the state of the art in clinical care.
Before we present the results, there are some important caveats related to this analysis
and comparison. First, comparison we present here is relatively underpowered. We compare
only 14 experiments—meals—for three experimental set-ups, participant one’s glucose fore-
casts and measurements one hour and two hours post-meal and participant two’s glucose
forecasts and measurements two hours post meal. Recall that the dataset for participant 1
typically had two postprandial blood glucose measurements, while the dataset for partici-
pant 2 typically had only one postprandial blood glucose measurement. Because of this, we
do not have one-hour correlations for participant 2. Participant 3 did not have enough data
to calculate statistically significant one or two-hour post meal correlations between mea-
sured and forecasted glucose. Some of the quantities we would like to calculate are not
resolvable with these data, but we can make enough good estimates to make useful and
important comparisons. Second, the educators generally estimate the glycemic impact of a
meal not post-meal glucose at a precise time, making pin-point forecasts an unusual task for
them. Because of this, we might expect the linear correlation—the quantity that captures
accuracy the estimate of the mean—to be well forecast by the diabetes educators while the
MSE—the quantity that captures point-wise forecast error—to be more difficult for the dia-
betes educators. Third, the DAs are continuous models and generate a glucose forecast
every minute regardless of the data present. The continuous glucose dynamics are
Fig 2. Mean squared error integrated over time after day 7 for participant 1 for both ultradian and meal
models. Notice: both models show convergence in mean squared error over time; after 200 measurements
the integrated mean squared error for both models does not differentiate them; and as the number of
measurements increase, the majority of the errors are below the integrated mean squared error value.
https://doi.org/10.1371/journal.pcbi.1005232.g002
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oscillatory—like that of an oscillator driven by nutrition and damped by insulin and metab-
olism—so the model output can differ by 100 mg/dl within a 15 minute interval over the
first two hours after food has been consumed. The oscillations driven by meal consumption
for both models can be seen in Figs. 1 in S2 and S3 Appendices respectively. Because of this,
we might expect that the model forecasts would have high MSE and low linear correlation
with measurements at one hour post-meal and low MSE and high linear correlation at two
hours post-meal.
Table 2 has the results of the comparison between the diabetes educator post-meal glucose
forecast accuracy and the DA post-meal glucose forecast accuracy. The primary conclusion is
that the DA forecasts compare favorably to the forecasts of the certified diabetes educators
given the same data. This conclusion can be reached though five observations drawn from
Table 2. First, the DAs do not have good point-wise accuracy one hour after a meal as
expected. Second the DAs have better point-wise accuracy two hours after the meal in com-
parison with the point-wise accuracy of the diabetes educators, as expected. Third, the diabe-
tes educators have the same point-wise accuracy at one and two hours after the meal, but
their point-wise accuracy is higher than we had expected. Fourth it is difficult to compare the
linear correlation—the estimate of the post-meal mean—between the post-meal measure-
ment and forecasts of the diabetes educators and the DAs for participant one because of data
sparsity. And fifth, the linear correlations between the between the two hour post-meal mea-
surement and forecasts of the diabetes educators and the DAs for for participant two were
roughly comparable.
It is, of course, relatively easy for us to improve the DA performance such that the DAs will
outperform the diabetes educators if we tune the DA hyper-parameters by hand to a given
individual. But, one of the key points of this paper is to demonstrate that the DAs, with no
human intervention, can automatically generate a glucose forecast that is of similar or better
quality as a highly trained human expert. Given the likelihood that knowledge of Certified Dia-
betes Educators greatly exceeds knowledge of a typical individual with diabetes, it is likely that
DA-generated predictions will be more accurate than those generated by individuals with dia-
betes and therefore of potential help to individuals with type 2 diabetes.
Table 2. A comparison between the post-meal glucose forecasts of Certified Diabetes Educators and
the DAs for a subset of the meals consumed by participants one and two. The model forecasts compare
well with expert forecasts. There is no one-hour correlation for participant 2 because participant 2 did not have
one-hour post-meal glucose measurements.
Comparing DA forecasts with certified diabetes educator forecasts
Patient Forecast MSE LC
P1, 1 Hr, 14 Meals Ultradian Model 2400 -0.44, p = 0.11
Meal Model 1900 0.13, p = 0.65
Expert 1 870 0.36, p = 0.2
Expert 2 660 0.62, p = 0.02
P1, 2 Hr, 14 Meals Ultradian Model 520 0.18, p = 0.54
Meal Model 290 0.73, p = 0.003
Expert 1 890 0.14, p = 0.64
Expert 2 900 0.14, p = 0.55
P2, 2 Hr, 14 Meals Ultradian Model 570 0.77, p = 6e-4
Meal Model 1000 0.58, p = 0.02
Expert 1 470 0.72, p = 0.003
Expert 2 340 0.75, p = 0.001
https://doi.org/10.1371/journal.pcbi.1005232.t002
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DA-based personalized medicine: Model personalization and adaptation
People, their metabolism, their behavior, and their presentation of diabetes are both personal
and dynamic. To be useful, the DA must both personalize to the individual and adapt to
changes in the individual over time. The models forecast glucose based on three features: glu-
cose measurements, carbohydrate measurements, and model state defined by the parameter
settings. While glucose and carbohydrate dynamics change on fast time scales (order minutes
to hours), the baseline endocrine state and the model parameters that represent it are slower
moving variables with dynamics evolving on the order of days to months.
We estimate three parameters for each model every time a new measurement is encoun-
tered. The ultradian model parameters we personalize include the exchange rate for insulin
between remote and plasma compartments, E, the volume of insulin distribution in the
plasma, V1, and the time constant for plasma insulin degradation t1, all of which affect the glu-
cose mean and variance [69]. The meal model parameters that we estimate include the insulin
volume, VI, and the glucose kinetics parameters k1 and k2, both of which are related to the
severity of diabetes and also affect the glucose mean and variance.
To initially visualize and evaluate the adaptation of the models, we will first focus on
HbA1c as a long-term clinically-motivated proxy for glucose. The relationship between
HbA1c and glucose is understood physiologically and is well documented empirically [23]—
HbA1c is linearly related to the mean glucose value averaged over the previous 90 days. The
time period necessary to estimate HbA1c can be considerably shorter than 90 days, and the
lower bound on the length of this time window is unknown. The problem of predicting
HbA1c can then be framed as the challenge of determining the true mean glucose over such a
time window. However, because we are focusing on opportunities for real time decision sup-
port, it is of greater interest to relate short term behaviors to long-term outcomes. As such, we
explore methods for computing accurate daily glucose averages that can be easily converted to
proportional HbA1c values. Concretely, these daily HbA1c estimates represent the expected
HbA1c outcome for a patient if they were to maintain that day’s mean glucose over 90 days. In
Fig 3, we evaluate daily HbA1c estimates by computing daily mean glucose levels for patient-
recorded measurements and continuous off-data model forecasts.
Fig 3 shows the carbohydrate consumption of participants 1 and 2, daily HbA1c estimates,
and real HbA1c measurements. Embedded in Fig 3 are five important results. First, by observ-
ing the changes in carbohydrates, we can verify that participant 1 consistently reduced their
carbohydrate intake over the course of the study. Participant 2 also reduced their carbohydrate
consumption, but not consistently, and by the end of the study their mean glucose was trend-
ing upwards. Participant 1’s HbA1c changed in the course of the study, potentially due to the
change in carbohydrate consumption. For participant 2, the single HbA1c collected during the
study is consistent with the HbA1c estimates from both glucose measurements and forecasts.
Second, the results make evident the challenges related to estimating HbA1c on a time scale of
days from only glucose measurements taken in the course of self-management. The culprit is
sparsity of measurements; estimating a reliable and low-variance mean given 3–8 numbers
taken from an oscillatory signal is non-trivial. Importantly, mean glucose may be more stable
across days than is made apparent to patients by infrequent measurements.
Third, the smoothed, fast time scale HbA1c estimate computed from the continuous glucose
forecasts provided by the DA is more reliable, stable, and accurate than an estimate based on
glucose measurements collected with frequencies consistent with common practices of individu-
als with diabetes. It is possible that continuous or carefully selected glucose readings could be
as good or better than DA smoothing, however, neither of these approaches are feasible for the
majority of individuals with T2D. For participant 1, DA is able to overcome the data-quality
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deficit: the ultradian model forecasts participant 1’s second HbA1c measurement nearly per-
fectly. The models track mean glucose well and are able to provide real-time forecasts that give
us the ability to compute real-time smoothed mean glucose and HbA1c estimates, thus provid-
ing both a short-term glucose forecast and a long-term forecast of meals’ impact on glycemic
control. However, which of these model outputs are most useful for self-management remains
an open question. Fourth, both models track the HbA1c with expected accuracy. The glucose-
measurement estimated HbA1c is well tracked by a smoothed DA-based HbA1c estimate.
Fifth, the DA-based HbA1c forecasts seem to have a roughly 5-8 day lag behind nutrition as
can best be observed in the plot of participant 2’s HbA1c and carbohydrate dynamics. The car-
bohydrate and HbA1c trends are roughly 5 days out of phase. This suggests that, given the con-
straints imposed by real-world frequency of data collection, the DAs change the basic
endocrine state on the order of 5–8 days, or 50 measurements. This rate of adaptation is con-
sistent with the initial convergence rate that required roughly 5–8 days or 50 measurements to
converge. However, the key point is that the DAs continuously adapt and correct the endo-
crine basic state, improving forecasting accuracy, on the order of 50 measurements or 5–8
days, a speed that is likely fast enough to be useful in the context of diabetes self-management.
The convergence and adaptation of the model parameters estimated by the DA are shown
in Fig 4. This plot shows the evolution of three estimated parameters as new measurements
are encountered. There are four notable results in these figures. First, the model parameters
generally converge to a curve with much slower or no change after approximately 50
Fig 3. Top row—carbohydrate consumption in grams averaged every day for participants 1 and 2; participant 1 reported making dietary
changes during the course of the study, with a particular focus on reducing the amount of consumed carbohydrates, while participant 2 did
not report any changes in their diet during the study. Bottom row—HbA1c measurements for participants 1 and 2, measured-glucose-
based HbA1c estimate, and the associated continuous DA generated χo-based daily HbA1c smoothed estimates for both the meal and
ultradian models; the χo-based HbA1c forecasts are accurate and track broad glucose trends in all cases and the ultradian model HbA1c
forecast for participant 1 predicted both the trend and the final measured HbA1c value. The initial underestimate of participant 1’s HbA1c is
due to a combination of two factors: (i) the initial HbA1c measurement is taken at a time where the model error is high because it is early in
the sequential estimation process and (ii) the model training set does not include much data prior to the first HbA1c measurement.
https://doi.org/10.1371/journal.pcbi.1005232.g003
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measurements—this is consistent with the convergence rates we observed in the mean
squared error in Fig 2. Second, both models adapt continuously to participant 1 who consis-
tently decreased carbohydrate intake. The models show the adaptation to this change primar-
ily in a single parameter—the exchange rate for insulin between remote and plasma
compartments, E, of the ultradian model and the estimated insulin volume, VI, of the meal
model. Third, participant 3 did not have enough measurements to converge to a personalized
state, but it is clear that the convergence was underway because several of the parameters
appear to be leveling off to a constant state, following a qualitatively similar path as partici-
pant 2’s parameter convergence. This helps establish a measurement constraint, participant
3 has only 24 measurements and while the DA can issue better forecasts than a linear regres-
sion, the DA appears to need closer to 50 measurements to personalize. And fourth, the par-
ticipants were all in relatively different health states and the models evolved through
distinctly different health states, providing evidence of personalization.
Model selection: Identifying the best model to drive the DA for a person
and circumstance
We have no first principles type understanding of systems physiology, instead mechanistic
models are constructed using empirical observation and stylized facts as is often done in eco-
nomics [70]. Our object of study here, the endocrine system, is a complex, high dimensional
physiologic system that depends on spatial scales from the molecular to the societal and time
scales from microseconds to decades. We do not know which model with what components
will most accurately represent a given person in a given circumstance. Because of this, to
achieve accurate personalized forecast of glucose, it is important to include several different
models and to develop a methodology for selecting the most useful model for a given set of cir-
cumstances, or employ a model-averaging scheme [55–57]. For simplicity, here we have
Fig 4. Convergence in time, i.e., personalization of the DA, for three parameters of ultradian model (left) and three different parameters
for the meal model over the course of measurements for all five patients. Recall that the models have few overlapping parameters so it is not
possible to compare parameters between models. Notice: (i) each model converges to a different state, depending on the patients, personalizing
to the individual, (ii) visually, initial convergence of the parameters requires about 50 data points, (iii) patient 1, who continuously changed their
behavior, had parameters that evolved in time in contrast to patient 2 whose behavior did not evolve and whose parameters did not change
appreciably after 50 data points, and (iv) when using the meal model with patient 1, the potential for underfitting due to the sigma-point constraint in
the parameter filter can be observed at measurement 50—recall that the sigma-point constraints were added to ensure robustness of the UKF,
and that there exist methods for rectifying such issues, which we do not address.
https://doi.org/10.1371/journal.pcbi.1005232.g004
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restricted our choices to two mechanistic models and focus on model selection, rather than
model averaging.
There is neither an objectively best model nor an objectively best model evaluation method-
ology [55]. To present a holistic picture and triangulate an understanding of what the different
models do well and how they differ, we use four model selection techniques. Our first model
evaluation—mean glucose—is likely the most intuitive, but not the most robust or accurate
evaluation metric. Second, as previously discussed and seen in Fig 2, we use the pointwise
mean squared error. Third, we use an information criterion technique—the Kullback-Leibler
(KL)-divergence between the kernel density estimate of the real measurements and the kernel
density estimate of the forecasts [64]. The fourth method we use to evaluate model perfor-
mance is the linear correlation between DA forecasts and measured glucose values.
Forecast means in Table 3 show measured and DA-based mean glucose estimates for all
five participants. While all models produce reasonable results, the ultradian glucose forecasts
generate the most accurate mean glucose estimates. This result is surprising because the ultra-
dian model is the simpler model and does not reproduce the measured glucose distribution as
accurately as the meal model, as seen in Fig 5. The accuracy of the continuous off-data forecast
of the ultradian model is important because the continuous forecasts are produced every few
minutes, generating enough glucose values to render an accurate short term, e.g., 24 hour
HbA1c forecast that can illustrate long-term impact of immediate nutritional choices, an
option that is usually unavailable.
The KL-divergence is a measure of the distance between two probability density func-
tions—here the difference between glucose probability density function estimates. Small
KL-divergence implies the graphs of the two probability density functions are similar,
Table 3. Model evaluations for individual DA estimates is presented. KL designates the KL divergence between the kernel density estimate of measured
and DA-output glucose, LC designates linear correlation, potentially with a lag. Notice: (i) all models produce reasonable results, the ultradian mean glucose
forecasts are the most accurate, (ii) the accuracy of the continuous forecast is important because the forecasts are produced every minute, generating enough
glucose values to render an accurate short term HbA1c forecast that patients can immediately relate to their nutrition intake, (iii) the metrics do not always
select the same best model, (iv) no single model is the representative of all patients, and (v) both models are capable of representing and forecasting patients.
Model evaluation metrics of the DA forecasts
Participant 1 2 3 4 5
Disease state T2D T2D T2D no-T2D no-T2D
Mean glucose, measured 113 ± 25, (σ) 127 ± 32, (σ) 119 ± 16, (σ) 92 ± 17, (σ) 101 ± 16, (σ)
Mean glucose, ultradian model forecast 115 ± 15, (σ) 124 ± 12, (σ) 115 ± 9, (σ) 90 ± 13, (σ) 101 ± 12 (σ)
Mean glucose, ultradian model continuous forecast 116 ± 14, (σ) 129 ± 16, (σ) 120 ± 17, (σ) 91 ± 13, (σ) 100 ± 10, (σ)
Mean glucose, meal model forecast 105 ± 28, (σ) 120 ± 26, (σ) 126 ± 37, (σ) 87 ± 22, (σ) 97 ± 27, (σ)
Mean glucose, meal model continuous forecast 101 ± 15, (σ) 118 ± 28, (σ) 132 ± 35, (σ) 76 ± 19, (σ) 86 ± 17, (σ)
KL, Ultradian model and glucose 0.54 0.29 3.9 0.65 2.6
KL, Meal model and glucose 1.2 0.11 1.4 0.18 0.20
MSE, Ultradian model and glucose 680 950 250 260 280
MSE, Meal model and glucose 730 1300 2800 540 590
LC(1HR) Glucose with itself 0.3, p = 0.07 — — 0.1 p = 0.4 0.12 p = 0.3
LC (2HR) Glucose with itself −0.02, p = 0.9 0.07, p = 0.6 — −0.13 p = 0.11 0.18 p = 0.13
LC Ultradian model forecast with glucose 0.12, p = 0.04 0.33, p = 6.0e−7 0.10, p = 0.67 0.38, p = 9.0e−20 0.32 p = 5.0e−9
LC Meal model forecast with glucose 0.24, p = 3.5e−5 0.31, p = 6.0e−6 -0.47, p = 0.03 0.36 p = 3.0e−17 0.38, p = 4.0e−12
LC(1HR) Ultradian model forecast with glucose 0.31, p = 0.03 — — 0.39, p = 0.001 0.32, p = 0.006
LC(1HR) Meal model forecast with glucose 0.20, p = 0.16 — — 0.28 p = 0.02 0.29 p = 0.01
LC(2HR) Ultradian model forecast with glucose −0.11, p = 0.39 0.43, p = 0.004 — 0.44 p = 3.0e−9 0.18 p = 0.13
LC(2HR) Meal model forecast with glucose 0.07, p = 0.55 0.55, p = 8.6e−5 — 0.46, p = 7.3e−10 0.46, p = 4.0e−5
https://doi.org/10.1371/journal.pcbi.1005232.t003
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indicating good model estimates. Visual intuition of the KL-divergence can be gleaned from
Fig 5 that shows the kernel density estimates of the glucose measurements and forecasts for







where p and q are probability densities and μ is the Lebesgue measure. The KL-divergence
between p and q is interpreted as the information lost when p is approximated by q. For us, the
interpretation becomes more complex because of measurement biases—biases caused by the
missing values and the noise associated with them due to the self-monitoring data collection
process for an individual with diabetes. Here we compare the kernel density estimates of real,
sparse measurements, DA forecasts restricted to times where there are real glucose measure-
ments, and continuous DA-based imputation of glucose. The differences between the kernel
density estimates for these quantities shown in Fig 5 may be nontrivial. Without continuous
blood glucose monitoring, the true continuous distribution of glucose is unknown. Neverthe-
less, combining the information in Table 3 with what we observe in Fig 5 suggests that while
the measurements and model outputs all generate a similar mean glucose value, the graphs of
the kernel density estimates are qualitatively different. Moreover, it does appear that the kernel
density estimate of the meal model based forecasts most closely resembles the kernel density
estimate of the measured glucose values, while the mean of the ultradian model forecasts is
Fig 5. The kernel density estimates of the probability densities (PDFs) of glucose measurements and
a variety of forecasts after day 7 for participant 1 for both ultradian and meal models. These PDFs are
used to estimate the KL-divergence between the kernel density estimate of measured and model forecasted
glucose values. For this patient the PDF generated by the meal model appears to more closely resemble the
PDF generated by the measured glucose than the PDF generated by the ultradian model. Importantly, the
PDFs of the ultradian and meal models are distinct and different from one another, implying differing
physiologic processes and mechanisms present.
https://doi.org/10.1371/journal.pcbi.1005232.g005
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closer to the mean of measured glucose. This highlights why there is not an optimal method
for model selection. Contrasting different evaluation metrics, different integrals, allows for a
clearer picture of how well the models are performing.
The full summary of the model evaluation shown in Table 3 presents a consistent vision.
For participants 1, 2, 4 and 5 the ultradian model generally matches or outperforms the meal
model, except when it comes to the linear correlation between forecast and measurement likely
because the ultradian model represents an estimate of the mean. For participant 3, the ultra-
dian model outperforms the meal model. This implies that even in our simplified situation,
there is clearly no best model for all patients and model evaluation metrics, although the ultra-
dian model does appear to be the better choice unless estimation of a distributional or linear
correlation based quantity is the desired goal. Most importantly, both models perform quite
well, implying that any choice have the potential to yield accurate forecasts.
Model averaging—Blending models to achieve a more accurate forecast
Finding an optimal model average relative to different quality metrics. The first ques-
tion to ask is what value of w1, when applied uniformly in retrospect to all forecasts, optimizes
model evaluation metrics. Fig 6 depicts the relationship between the averaging parameter, w1,
for ultradian model and meal model output versus mean square error, KL divergence, and lin-
ear correlation. All metrics for all patients are optimized (shown by the squares in the plot) by
weighting a portion of each model. The optimal weights for MSE and LC are both between
0.5–0.8, favoring a larger proportion of the ultradian model. The KL divergence also shows
local minima in this range for all patients, although KL also tends to be low for w1 = 0 (i.e.
meal model forecasts only). These results push three conclusions. First, model averaging, even
in relatively simple implementations, can improve forecast accuracy. Second, model averaging
re-enforces what we observed in Table 3, that choosing an optimal model can depend on the
quality metric being optimized. And third, for clinical applications, it will be necessary to care-
fully choose the quality metric that will most usefully help patients and clinicians make bedside
decisions.
Model averaging by optimizing a single quality metric. A straight-forward method of
picking model weights for a forecasting task is to use the weighting that optimizes a particular
metric for all previous forecasts. The efficacy of this approach can be evaluated by looking for
improvements not only in the optimized metric, but in other metrics as well. In Table 4, we
report the MSE, LC, and KL evaluations of forecasts that were generated with model weights
that were selected at each forecasting step to optimize one of the three metrics for all past data.
In all cases except P3, MSE-based averaging outperformed both models in MSE, and the
LC-based averaging forecasts outperformed both models in LC for two of the five patients. KL-
based model averaging underperformed noticeably, since it produced an inferior KL-divergence
when compared with the meal model alone for four of five patients. Moreover, KL-based
model average forecasts tended to have higher MSE as compared with other methods.
The results in Table 4 demonstrate that the ideal model averaging scheme varies across
patients. Forecasts for P1 were best optimized by an MSE-based average or MSE and KL,
whereas forecasts for P3 were best optimized for MSE and LC by the KL-based average. Opti-
mal averaging schemes for P2, P4, and P5 varied more greatly depending on the metrics we
wish to optimize. Overall, the MSE-based average seems to be a good choice for everyone
except P3, who collected far fewer data points than the other four participants. KL-based aver-
aging achieved high ranking results for P2 and P5, but, interestingly, other methods do a better
job of improving the KL divergence.
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Time variation in model averaging weights. It is also informative to explore how each of
these evaluation-based weighting schemes would function in an applied setting by plotting
their efficacy in time, along with the weights selected at each point by each method. This allows
us to evaluate if and when an ideal model averaging metric is knowable. In Fig 7, we see that for
P1, it was beneficial overall to favor ultradian forecasts. When optimizing MSE, the ultradian
forecasts proved more valuable, whereas optimizing LC required a more even pairing across
Fig 6. Mean square error, KL-divergence, and linear correlation for the entire set of forecasts for each participant was plotted
with respect to ultradian model weight. Boxes represent the points at which each metric is optimized. Note that most optima exist
between 0.5–0.8. Both mean square error and linear correlation have single inflection points, whereas KL-divergence takes on many
local minima. The presence of optimal weights that are far from both 0 and 1 indicate the potential value of model averaging in this
context.
https://doi.org/10.1371/journal.pcbi.1005232.g006
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models. The performance of model averaging in time for P1 shows that better model averaging
methods revealed themselves within 50–100 measurements (MSE-based and LC-based averag-
ing already achieved improved MSE and LC scores after 50 measurements compared to the
individual model performance). After 100 measurements, all participants’ forecasts were
improved by model averaging methods that, indeed, remained valuable throughout the rest of
the patient timeline. In some cases, an additional 50 forecasts were needed to perform an
informed model selection across averaging approaches, but most often, the first 100 measure-
ments were sufficient to determine the optimal model selection strategy.
The impacts of mechanisms and filtering analysis
We have shown that the DA converges given our clinical data constraints, the DA personalizes
to an individual, and that averaging models can help produce a better forecast. To demonstrate
the impact and necessity of the state and parameter filters and the mechanistic UKF set up as
well as comparing the DA to standard non-mechanism-based forecasting machines, we must
turn off the various filters and implement different forecasting machinery and observe how
the forecasts accuracy changes. Table 5 shows the mean forecasted glucose and the mean
square error and KL-divergence between the measured and the forecast glucose values. This
Table 4. Model averaging with sequential weight selection, based on mean square error, KL-divergence, and linear correlation, is evaluated for all
three performance metrics and compared to the performance of individual models. Values are bolded to designate the model that performs best under
each criterion for each participant. While MSE-based averaging consistently outperformed the individual models, the ideal scheme varies across patients.
Evaluation of DA-based model forecast averaging
Patient DA/averaging MSE LC KL
P1 Ultradian Model 750 0.12 0.55
Meal Model 1110 0.24 1.2
MSE-based average 640 0.21 0.25
LC-based average 850 0.23 2.6
KL-based average 810 0.18 3.2
P2 Ultradian Model 920 0.33 0.72
Meal Model 1250 0.31 0.11
MSE-based average 905 0.37 0.75
LC-based average 990 0.36 0.18
KL-based average 960 0.37 0.07
P3 Ultradian Model 310 0.1 3.0
Meal Model 2100 -0.47 1.6
MSE-based average 480 -0.25 3.3
LC-based average 300 0.13 3.1
KL-based average 370 0.0088 3.2
P4 Ultradian Model 280.6004 0.3846 0.6477
Meal Model 520 0.36 0.18
MSE-based average 240 0.48 0.29
LC-based average 270 0.46 0.23
KL-based average 360 0.39 0.49
P5 Ultradian Model 280 0.32 2.6
Meal Model 700 0.3751 0.18
MSE-based average 260 0.38 3.0
LC-based average 330 0.35 0.95
KL-based average 280 0.44 0.91
https://doi.org/10.1371/journal.pcbi.1005232.t004
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table prompts two comparisons—the DA with different filters included and the dual UKF DA
with the GPMR.
To demonstrate the impacts of the state and parameter filters, we consider three DAs: (i)
no-filter—we set the initial glucose and nutrition to be the latest measurement and run it for-
ward to the next measurement; (ii) state-filter—were we run the UKF state filter but not the
parameter filter, and (iii) the dual UKF state and parameter filters. In this setting the mean for
the state and no-filter is mostly determined by the initial parameter settings because the
Fig 7. The progression of model averaging performance is shown for P1, along with the weights selected by each
method at each forecasting step. MSE-based and LC-based averaging show immediate improvements in their respective
quantities, and are able to strike a balance between the high linear correlation of the meal model and the low MSE of the ultradian
model. For P1, only the MSE-based average improved long-term KL divergence. In addition, the MSE-based average achieved
better error than the ultradian model while nearly doubling the correlation of its forecasts with real measurements. This pattern
becomes evident within the first 75 forecasts, demonstrating the feasibility and utility of doing model selection across model
averaging modalities.
https://doi.org/10.1371/journal.pcbi.1005232.g007
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parameters are not changed. There are four results of note. First, the effects of the different fil-
tering constructions was consistent between models. Second, we did not observe much differ-
ence between the state filter and the no-filter DAs. Third, the dual filter, which includes
parameter correction, provides a substantial improvement over the no-filter and the state-only
filters with respect to the accuracy of the mean and pointwise mean square error. Fourth, the
Table 5. Comparing filters and a non-mechanistic forecasting machine. The different filter configurations include all filters off, state-only filters and dual
(state and parameter) filters enabled. The non-mechanistic forecast is provided by the Gaussian Process Model Regression (GPMR). In all but one case, the
dual UKF based on the ultradian model provides the most accurate forecast—although model averaging in Table 4 provides an even more accurate forecast.
While the GPMR does have a potentially useful MSE, it is not as useful for tracking the mean glucose state because it is trained only on glucose measure-
ments surrounding meal times.
Model and filtering comparison
Patient Model Filter Mean BG Forecast mean BG MSE KL
P1 Ultradian no-filter 115 ± 15 109 ± 15 770 0.04
state filter 108 ± 18 780 0.29
dual filter 115 ± 15 680 0.54
Meal no-filter 109 ± 15 3600 0.06
state filter 108 ± 18 2100 0.19
dual filter 105 ± 28 730 1.2
GPMR 130 ± 9 630 0.30
P2 Ultradian no-filter 127 ± 32 107 ± 6 1800 0.14
state filter 107 ± 8 1800 0.35
dual filter 124 ± 12 950 0.29
Meal no-filter 107 ± 6 1800 0.07
state filter 107 ± 9 1700 0.03
dual filter 120 ± 26 1300 0.11
GPMR 140 ± 17 1200 0.08
P3 Ultradian no-filter 119 ± 16 107 ± 7 330 0.36
state filter 107 ± 7 330 1.33
dual filter 115 ± 9 250 3.9
Meal no-filter 107 ± 7 3500 2.9
state filter 107 ± 7 3500 2.7
dual filter 126 ± 37 2800 1.4
GPM — — —
P4 Ultradian no-filter 92 ± 17 108 ± 17 640 0.60
state filter 108 ± 17 630 0.97
dual filter 90 ± 13 260 0.65
Meal no-filter 108 ± 17 7000 0.34
state filter 107 ± 7 5300 2.1
dual filter 87 ± 22 540 1.4
GPM 93 ± 4 330 0.57
P5 Ultradian no-filter 101 ± 16 110 ± 14 500 0.2
state filter 110 ± 14 500 0.27
dual filter 101 ± 12 280 2.6
Meal no-filter 110 ± 14 4000 0.16
state filter 110 ± 14 2800 0.14
dual filter 97 ± 27 590 0.20
GPM 110 ± 5 350 0.17
https://doi.org/10.1371/journal.pcbi.1005232.t005
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KL-divergence is usually minimized by the no-filter and the state filter, but none of the KL-
divergences are particularly large.
Comparing the dual UKF powered by mechanistic models with a non-mechanistic
machine is difficult to make completely equitable or unbiased, largely because the natural
input and training sets for the two different models are so different. The UKF really track
and re-aligns the mechanistic model using whatever data are currently available, substituting
model data for any missing data maintaining a continuous-time model of the system where
as the GPMR is a regression that takes a full input vector and maps it to an output vector. It
is possible that with a continuous glucose monitor data such a comparison between the
GPMR and the UKF would be more equitable, but this is not the situation we address in this
paper. The dual UKF forecasts were generated as previously discussed. The GPMR forecasts
were generated using data for meals restricted to the situation where there is a pre-meal glu-
cose taken within 15 minutes of eating the meal, a post-meal glucose taken within 45–180
minutes of the beginning of the meal—the most recent post-meal glucose is always used as
the post-meal glucose—and of course carbohydrate estimates. The GPRM is trained on the
first 50 meals and when it encounters a new meal, it makes a forecast based on the pre-meal
glucose and carbohydrate estimates, and then that meal is added to the training set. The
GPMR can be very sensitive to nonstationarity—participants 1 and 2 in particular—and
when it is, the its accuracy is highly sensitive to the training window length. We chose the
training and forecasting procedure to minimize the dependence on the training window
size. Relative to this construction we have four key results. First, the GPMR generally overes-
timates the mean glucose by a substantial amount, expect for participant 4. Second, the
GPMR has a competitive MSE—is is usually the second lowest compared with the dual UKF
using the ultradian model. The KL divergence for the GPMR is low and usually preforms
about as well as the no-filter DA, likely because both the processes are Gaussian without too
much imposed mechanistic structure. And fourth, if we instead use a fixed window size,
unless the meal training window is short—less than 50 meals—the GPMR performs consid-
erably more poorly than any of the dual UKF implementations. We will save more analysis
of the GPMR for another time.
Building blocks for a diabetes management intervention
The underlying expectation of this research is that generating accurate predictions of individu-
als’ glycemic response to particular meals can inform their decision-making and improve their
glycemic control. Our final objective, then, is to examine different ways of communicating pre-
dictions generated with DA that provide actionable information and convey different degrees
of confidence and precision. The natural output of the model is a continuous forecast with a
potentially indefinite endpoint, and there exist many different ways to present this information
to individuals with diabetes in order to inform their decisions. Previous research suggested that
visualizing these projections in a graphical way, as a continuous curve, can lead to improved
understanding [71]. Another possibility is to condense this continuous forecast into a projected
range that communicates to the individual the anticipated glycemic impact of the meal. While
traditional static error terms communicate average forecast uncertainty, they do not convey
higher-order information (e.g. extreme values, velocity) that are relevant to understanding the
case-specific effects of nutrition. Instead, we consider different ways of generating interval pre-
dictions that reflect expected fluctuations in blood glucose and have the added benefit of com-
municating forecast uncertainty. Specifically, we examine three dynamic forecast intervals
derived from continuous DA output and characterize them by comparing the magnitude of
their bounds with an empirical estimate of the confidence interval they represent.
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The left plot of Fig 8 shows the last 25 glucose measurements and three model-derived
dynamic bounds on a moving window, ± standard deviation, ± variance, and range (maximum
minus minimum) of the continuous ultradian model-based glucose forecast 30–120 minutes
after a meal. The right plot shows percentage of measurements captured by those boundaries.
Recalling Fig 1, the ultradian model has high amplitude oscillations while the meal model has
limited oscillations; this dynamic difference has a profound impact on which model may pro-
vide the most useful forecast boundary. Generally, the ultradian model forecasts capture a
higher percentage of future measurements. The variance is too wide to be useful for any of our
participants. The ultradian model range provides a better balance of frequency of accuracy; the
dynamic range of ±15–20 capturing 50–60% of future measurements compared to standard
deviation of ±15 capturing 40% of future measurements. Here participant 3 is the exception
with a standard deviation of ±25 capturing 82% of future measurements. This difference dem-
onstrates the complexity of translating a forecast that is a density into a quantity such as a sin-
gle number—the ideal range may have to be chosen automatically for a given person. These
results are a proof in principle that a plausibly useful forecast range could be created.
Discussion
The broad goal of this research is to develop new ways to forecast postprandial blood glucose
levels given an individual’s preprandial blood glucose level and nutritional composition of a
meal, particularly amount of carbohydrates. To achieve this goal we developed a DA and inte-
grated it with two mechanistic endocrine models, a model averaging methodology, and a
dynamical Gaussian process model regression, largely for comparison purposes. We can
observe the DA personalizing the models by estimating model parameters for individuals in
real-time with as few as 50 glucose measurements. We then formulated model selection to
Fig 8. Practical forecast accuracy of DA forecasts can be captured by calculating the percentage of measurements that are contained
within glucose forecast-derived forecast ranges. Here we consider three such ranges, standard deviation, variance, and range of the glucose
forecast 30–120 minutes after a given meal. The left plot shows the last 25 glucose measurements of participant 1 and a moving window of the
ultradian model-based off-data forecast ranges. From this we can see how the windowed forecast ranges predict the glucose value: the variance
is too wide to be useful but contains all measurements, and the range encapsulates proportionally more measurements as the more narrow
standard deviation. The right plot shows the percentage of post meal measurements captures versus with width of the boundary window.
https://doi.org/10.1371/journal.pcbi.1005232.g008
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choose the right model for the individual in a way that is generalizable and allows for inclusion
of additional models if necessary. Similarly, we constructed a model averaging methodology to
demonstrate that more accurate predictions can be achieved by averaging models. Our reasons
for selecting a DA framework were that it allows for incorporation of systems physiology
knowledge into the forecast to reduce reliance on dense historical data, and to generate reliable
predictions based on sparse data, consistent with existing self-monitoring guidelines and prac-
tices, typically available to individuals with diabetes.
We then tested the proposed models using data collected by three individuals with diabetes
and two without diabetes. These datasets were selected because they illustrated different self-
monitoring scenarios, had different unique properties, and allowed us to test the models under
different sets of constraints. In our study, the DA: (i) estimated the data well in real time
according to standard model evaluation metrics; (ii) produced forecasts that compared favor-
ably with the forecasts of certified diabetes educators whose judgment the gold standard for
devising personalized nutritional recommendations for individuals with diabetes and repre-
sents the best available human-based glucose forecasting; (iii) personalized the model to an
individual and adapted as the individual changed, providing a personalized medicine approach
to diabetes treatment; (iv) was integrated with model selection machinery that differentiated
model types according to how they estimated the data, allowing a best model to be chosen; (v)
preformed well given realistic self-monitoring data quality; (vi) had accurate output at a high
enough frequency, potentially forming the basis for a self-management intervention, and (vii)
could be averaged in real time to produce even more accurate forecasts.
An ability to accurately forecast postprandial glucose levels has a number of important clin-
ical implications. There exists a considerable body of evidence showing that postprandial
hyperglycemia contributes substantially to cardiovascular risks and other complications of dia-
betes [72], [73]. Previous research argued that an ability to generate accurate predictions of
postprandial blood glucose can enable personalized self-management interventions, for exam-
ple personalized meal planning [31]. We propose that the computational machinery described
here could be applied more directly to display glucose forecasts to individuals in order to
inform their nutritional choices. Yet communicating predictions with a degree of uncertainty
in a useful way is non-trivial, as is evidenced from the extensive research on communicating
weather forecasts [74]. In the context of health and health management, the research on com-
municating risks and uncertainties has primarily focused on informing significant, potentially
life-changing decisions, such as surgery, rather than such mundane common decisions as daily
meal choices [75]. Moreover, generating glucose forecasts in real time requires accurate mac-
ronutrient assessment of meals. Previous research has suggested leveraging crowdsourcing
communities for generating timely and accurate nutritional assessments of meals based on
these meals’ photographs [76]. Still, more research is needed to identify ways to implement
DA-based forecasting to facilitate nutritional decision-making in real-world settings.
Originally designed to guide satellites, control chemical plants and electrical grids, and fore-
cast weather, DA has mostly been applied to data-rich situations outside of biomedicine. Inside
the biomedical context, DA and control are used in pacemakers, to treat cancer, and to treat
patients with type 1 diabetes. The unique advantage of DA is that it infuses data with human
knowledge, thus allowing the model to quickly adapt to environmental changes, cope with
highly nonlinear systems, and confront forecasting problems, all while reducing reliance on
data in real time. This is particularly important for such complex multi-dimensional systems
as the human endocrine system and blood glucose regulation. Previous research already estab-
lished feasibility of using machine learning for forecasting individuals’ postprandial blood glu-
cose levels based on nutrition, physical activity, and sleep, while incorporating individuals’
personal clinical and microbiome profiles [31]. Moreover, this work showed that such
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predictions could be used to inform personalized nutritional interventions. However, because
the traditional machine learning approaches do not incorporate knowledge of human physiol-
ogy, they require massive amounts of relatively clean data that, in the case of diabetes, can only
be generated with continuous glucose monitoring. Yet continuous glucose monitoring is not a
recommended practice for the vast majority of individuals with diabetes, who continue to rely
on infrequent blood glucose measures taken with commercial blood glucose meters. The DA
approach is uniquely positioned to reduce the need for data and provide a viable solution with
a high translational potential.
The DA methodology can also be used to demonstrate the difficulty of the problem-solving
task facing individuals with type 2 diabetes. For the individuals without type 2 diabetes, the
point-wise accuracy of the DA forecasts quickly converged to approximately the error present
in the glucose measurements—a MSE of 250 translates to about 15 mg/dl of accuracy. In con-
trast, the point-wise predictive accuracy of the glucose forecasts for the participants with type 2
diabetes was on the order of 500—approximately 22 mg/dl—for both the diabetes educators
and the DA. This implies that people with type 2 diabetes seem to face a more difficult glyce-
mic impact prediction task than people who do not have type 2 diabetes, as is reflected in both
the diabetes educators and the DA’s ability accurately forecast glucose.
Reaching beyond the direct clinical translation, the DA approach has the potential to forge
a deeper understanding of physiology due to its dependency on mechanistic physiology for
generating forecasts. The DA allows the ability to exchange and evaluate different mechanistic
models with different mechanistic features and observe how adding or subtracting mechanistic
components affects forecasts and inferences. In this way the DA enables causal analysis
because it allows researchers to perturb the system that generates the observable data in time
and observe the effects—in other words, perturb the mapping between the mechanistic models
that govern the glucose-insulin dynamics [77]. The potential of such causal and comparative
analysis is apparent when observing the differences in the forecasts shown in Fig 5 and
Table 3. Higher frequency measurements would enable further probing of what physiologic
mechanisms are the most important drivers of glucose dynamics. Exchanging different mecha-
nistic engines in the context of DA can promote a better understanding of the mechanisms of
the generating process; this goal motivates several data-science challenges. Because forecasts
can depend on the DA implementation, there is a need to evaluate the forecasting ability of dif-
ferent DAs. In addition, there is a need for a systematic methodology for relating models with
different parameters and mechanisms to one another; if one model with few parameters is a
subset of a larger model class, comparing the two only accomplishes a dimensionality reduc-
tion of parameter space, and does not probe fundamentally different physiology. Moreover,
there is a need for an efficient means of choosing which model parameters to estimate. Finally,
there is a need for efficient and accurate methods for patient-specific, real-time optimization
of important DA hyper-parameters, such as assumed measurement and process noise.
By design, we restricted our data set to five differently measured, distinct individuals who
were all measured relatively sparsely to delve deeply into how DA performs in a practical,
patient-level diabetes setting, but this approach has limitations. We could not perform a pop-
ulation-scale analysis, nor could we evaluate which model best reproduced postprandial con-
tinuous glucose dynamics, as was done with machine learning models in [31]. Nevertheless,
we were able to show some boundaries for useful prediction and convergence (about 50 glu-
cose measurements combined with recorded carbohydrates), and we were able to demon-
strate how the knowledge embedded in the DA can make up for poor data conditions.
Similarly, while the use of a mechanistic model and DA potentially requires substantially less
data to achieve an accurate forecast, this choice narrows the ability to fit data and could
exclude a good solution if the model cannot represent the physiology of the individual. The
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fact that forecasts for each individual converged to different levels of error is evidence of
these person-specific model errors. Moreover, P3, P4, and P5 converged to mean error rates
similar to the error of the glucometers used to make measurements (mean absolute forecast
errors were under 15%, which is the maximum error tolerance permitted for most commer-
cially available glucometers).
Our vision for the use of data assimilation in clinical and biological
contexts
Alternative methods of parameter estimation. In this paper we chose to use a dual UKF
parameter filter to estimate parameters. We made this choice because the UKF has been
shown to work well in online situations with minimal tinkering. We could have similarly cho-
sen an Ensemble Kalman Filter [78, 79] or a Particle Filter [5, 79] and those filters would likely
work well. It would be useful to compare different filtering techniques, but to do so would
require optimizing the filters, a task we purposely did not do because we are focused on apply-
ing the filter to a large population soon in a way that can scale large populations. It is likely
that there is some space for improvement of parameter estimation using sophisticated meth-
ods, such as Markov Chain Monte Carlo methods [55] (MCMC), offline to provide better
starting and intermittent parameter estimates.
Optimizing parameters, hyperparameters, and properties. The goal of this paper is a
proof in principle that we could create an online model-based forecasting machine for predict-
ing glucose for people with type 2 diabetes that is practically scalable to a large population. By
doing this we ignored first principles parameter selection, hyperparameter optimization, and
general tweaking of the models or DA. This means that there is a lot of space for improvement
for all the methods and models. Selecting more useful mechanistic model parameters would
improve model and forecasting accuracy. Similarly, adapting noise-related parameters in real
time, e.g., R and Q, or parameters that are sensitive to measurement frequency would likely
increase forecast performance. Nearly every UKF hyperparameter could potentially be opti-
mized and many would result in forecast accuracy improvements. The same is true for the
non-mechanistic machinery. With the GPMR, for example, it is clear that the training window
must be optimized in real-time to make this machine adaptable and useful in real world situa-
tions. There is much space remaining for further innovation.
Mechanistic model averaging. We demonstrated that it is possible to average models to
get a more accurate forecast. We have three comments regarding these results. First, there do
exist many different mechanistic glucose-insulin models—for a comprehensive list of linear,
nonlinear, and comprehensive models, cf chapter 4 of [8]—therefore it would be relatively
easy to add more models to potentially achieve an ever more accurate glucose forecast. Second,
we used elementary model averaging machinery. It is easy to imagine using a Bayesian frame-
work for averaging models and their output that would produce improved results, especially
when the number of models is increased and may include non-mechanistic models. Third,
from the perspective of biological fidelity, it maybe be possible to reduce model error by add-
ing biologically orthogonal models, models that contain weakly interacting mechanisms, or
models that operate on different time-scales. We suspect that such an effect is the reason why
model averaging worked so well our construction. Specifically, the ultradian model dynamics
are on a fast time scale—oscillations on the order of minutes—whereas the meal model tends
to capture slower speed dynamics and usually misses the faster oscillatory dynamics. Because
of this—in the Fourier-frequency coordinate system sense of breaking the signals down into
amplitudes and frequencies of sinusoid functions—these two models are somewhat orthogonal
in frequency space. In this way, by averaging in this setting we may be both decreasing model
Glucose forecasting for type 2 diabetes
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005232 April 27, 2017 31 / 38
and forecast error; such may not always be the case. Further investigation of this interesting
hypothesis will have to wait for another paper.
Mechanistic model comparison. It is very difficult to quantify or compare either model’s
biological fidelity with the restricted data set we use in this paper—we cannot and do not
intend to claim superiority of either model in any objective sense. Similarly, given the limited,
clinically realistic data set and complex parameter space where some of the parameters have
codependencies, we assume we cannot claim to have achieved a globally optimal model esti-
mate—and such an estimate was not the goal of this paper. The models powering the DA are
not general purpose models but mechanistic models with specific physiological constraints.
Having more parameters does not translate to complete freedom—in fact, the interrelation-
ships between the parameters of the models are not well understood and can cause obvious
problems with parameter estimation. For example, we know that there are parameters we can
add to the set being estimated for both models that will, given the data we have, make the MSE
forecasts worse and visa versa. Checking all parameter combinations is, especially in real time,
hopelessly out of our computational reach. In general, selecting an optimal set of parameters
to estimate is a very difficult task—this is why did made our selections based on biological
insight constrained by a clinical task. Finally, the models were designed for different purposes,
and are, in some sense, orthogonal—we see the shadow of this in the model averaging results
where adding the models together made a better forecast implying some degree of indepen-
dence of the models. We can claim that, relative to a given evaluation metric, particular data
set, subset of parameters being estimated, and initial conditions for those parameters, one
model can out perform another. This conclusion is supported by Tables 3–5, and even for dif-
ferent metrics, the metrics sometimes conflict as to which model is the most accurate—model
selection is evaluation-metric-dependent.
Phenotyping and understanding disease progression. A very natural goal using DA
and mechanistic modeling is to compute an endocrine-related phenotype defined by the
model parameters—doing this and linking it to a genome-wide or phenome-wide associa-
tion study may help identify diabetes subtypes, help predict onset of type 2 diabetes, and
deepen our physiologic understanding of diabetes. While much work has been done in pre-
dicting diabetes onset in at-risk adult populations, longer prediction horizons (i.e. identify-
ing latent susceptibilities in young children) would be of exceptional clinical and biological
import due to the opportunities for meaningful interventions and the enhanced understand-
ing of long-term endocrine dynamics. Understanding the mechanics of the transition into
type 2 diabetes, whether it is simply a smooth change of state or a bifurcation with or without
hysteresis, is a different story entirely, but such an understanding requires a strong belief in
the biological fidelity of the models. At the heart of this and the phenotyping problem lies
the task of addressing model error—or forging an argument that the model and all its
parameters do represent the real physiologic processes. To attain adequate biological fidelity,
we would likely need to fit all model parameters, control for uncertainty in the parameter
estimates, provide external validation, and have mechanistic explanations for the parameter
estimates. This task requires more data than is used in this paper because, at the very least, it
would require external information—e.g., markers for other physiologic processes such as
liver and kidney function—and doing so was neither the goal of, nor within the scope of,
this paper.
Model error. We have shown that the models personalize to individuals, and there are
hints that they do so according to real physiology. We have even seen that Ultradian model
error rates for P3, P4, and P5 approach the levels of glucose meter accuracy. Nevertheless,
there are obvious limitations to the models implemented—they do not explicitly model many
processes known to influence the glucose-insulin system, including stress, exercise, and sleep.
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Moreover, current models of the glucose-insulin system parameterize nutrition only in terms
of carbohydrates, and do not consider the impact of other macronutrients, like protein, fiber,
and fat. We have already seen evidence for protein, fiber, and fat-based model errors by identi-
fying significant correlations between forecasting errors and non-carbohydrate meal content.
While model improvement is an essential part of accounting for these errors and improving
biological fidelity, there also exist opportunites in both machine learning and data assimilation
for real-time error correction.
Realism and clinical data. Self-monitoring among people with type 2 diabetes is a per-
sonal process that has great variability depending on the disease state, personality, and socio-
economic status. The data of participants 1 and 2 in this paper represents a realistic best-case
well measured patient with type 2 diabetes. A more common data type might be the data of
participant 3 who has sparse measurements—sometimes a measurement a day, sometimes a
measurement a week, and sometimes several measurements a day. Currently we do not know
the bounds of what patients are willing to self-monitor and we do not know the most effective
data measurement frequency for powering the DAs. It is clear that machine learning is difficult
to use in this context—we could not use participant 3’s data to estimate the GPMR for example
because there were not enough data that satisfied the data constraints of the GPMR. We knew
about this problem in advance which is why we choose to leverage the physiologic knowledge
and online estimation capacity of data assimilation. While it may be tempting to use simulated
data to find the optimal measurement frequency or pattern, the problem with using simulated
data in this setting is twofold. First, patients do not measure randomly. And second, the real
processes driving the physiology are nonstationary and may lie outside what the models typi-
cally include—e.g., behaviors such as exercise levels.
Filter sensitivity. The results we present in this work are specific to the UKF construction
outlined in detail in the appendix. It is important to understand that we can perturb the filter-
ing scheme and get different results; e.g., we know of several filter characteristics we can
change that flip which model performs better according to the MSE. We choose the filtering
construction not to necessarily optimize the MSE for all people or models, but as a balance
between robustness to different people against goodness of fit. But, this brings up two prob-
lems that we have attempted to solve by hand but would be valuable problems to solve in a
more general setting with a more firm theoretical foundation: robustness of the filter to pertur-
bations of the filter and optimal filtering choice. We do not have good answers for either of
these questions from either an analytical or computational framework, but the paper provides
clear practical motivation for solving those problems.
Nutrition sensitivity. Nutrition is the first order driver of glucose and insulin dynamics.
In our study, we established a protocol for nutritionists to follow when estimating the nutri-
tional content of meals and multiple nutritionists estimated meal content for every participant.
It is assumed that there is some noise and some bias in the nutritional estimates of the nutri-
tionists, but we do not have a good understanding of the filter sensitivity to nutritionist-gener-
ated noise, noise that could be systematic. We did have, in some cases, multiple nutritionists
provide nutrition estimates for the same meals and observed a consistency across nutritionists,
but if this machinery is made high-throughput, understanding the sensitivity of the filters to
nutrition estimates will be important.
Conclusion
We found that the DA estimated future glucose in a personalized way and showed via model
selection that different models have unique advantages, depending on the task (prediction,
inference, etc.) and the data source (i.e. patient). There exist certain lower-bounds on data
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quality for DA-based forecasting, but found these constraints to be mild relative to typical self-
management expectations. Overall, we believe that DA-based forecasting is accurate enough,
frequently enough to form the basis for a self-management intervention.
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